Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer

[1] Pagani M(2010)The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization Med Clin North Am 94 835-852

[2] Davila Gonzales I(2000)Hypersensitivity reactions to chemotherapy drugs Allergol Immunol Clin 15 161-181

[3] Salazar Saez R(2001)A revised nomenclature for allergy An EAACI position statement from the EAACI nomenclature task force Allergy 56 813-824

[4] Moreno Rodilla E(2005)Clarification of terminology in drug safety Drug Saf 28 851-870

[5] Johansson S(2003)Hypersensitivity reactions to chemotherapeutic drugs Clin Rev Allergy Immunol 24 253-262

[6] Hourihane J(2009)Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents Ann Allergy Asthma Immunol 102 179-187

[7] Bousquet J(2012)Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma Supp Care Cancer 20 385-393

[8] Aronson JK(2001)Weekly dosing of carboplatin increases risk of allergy in children J Pediatr Hematol Oncol 23 349-352

[9] Ferner RE(2001)Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy J Clin Oncol 19 3126-3129

[10] Shepherd GM(2003)Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity J Clin Oncol 21 4611-4614

[1] Pagani M(2010)The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization Med Clin North Am 94 835-852

[2] Davila Gonzales I(2000)Hypersensitivity reactions to chemotherapy drugs Allergol Immunol Clin 15 161-181

[3] Salazar Saez R(2001)A revised nomenclature for allergy An EAACI position statement from the EAACI nomenclature task force Allergy 56 813-824

[4] Moreno Rodilla E(2005)Clarification of terminology in drug safety Drug Saf 28 851-870

[5] Johansson S(2003)Hypersensitivity reactions to chemotherapeutic drugs Clin Rev Allergy Immunol 24 253-262

[6] Hourihane J(2009)Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents Ann Allergy Asthma Immunol 102 179-187

[7] Bousquet J(2012)Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma Supp Care Cancer 20 385-393

[8] Aronson JK(2001)Weekly dosing of carboplatin increases risk of allergy in children J Pediatr Hematol Oncol 23 349-352

[9] Ferner RE(2001)Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy J Clin Oncol 19 3126-3129

[10] Shepherd GM(2003)Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity J Clin Oncol 21 4611-4614